Cryptococcal meningitis in the immunocompromised host: Intracranial hypertension and other complications

Mycopathologia

Volumn 146, Issue 1, 1999, Pages 1-8

  Stevens, David A ^a,b,c,g   Denning, David W ^d   Shatsky, Stanley ^g   Armstrong, Robert W ^a,b,e   Adler, Jacqueline D ^a,b,c   Lewis, Bradley H ^f  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e Good Samaritan Hospital San Jose   (United States)

^f Alta Bates Hospital   (United States)

^g Sta Clara Valley Med Ctr ^*

Author keywords

AIDS; Cryptococcosis; Fungal meningitis; Immunocompromised; Intracranial hypertension

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CRYPTOCOCCAL MENINGITIS; HUMAN; IMMUNE DEFICIENCY; INTRACRANIAL HYPERTENSION; MALE; MORTALITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; HUMANS; IMMUNOCOMPROMISED HOST; INTRACRANIAL HYPERTENSION; MALE; MENINGITIS, CRYPTOCOCCAL;

EID: 0033490562     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007031514495     Document Type: Article

References (30)

1. Kwon-Chung KJ, Bennett JE, eds. Cryptococcosis. In: Medical Mycology. Philadelphia: Lea and Febiger, 1992: 397-446.
2. Zimmerman LE, Rappaport H. Occurrence of cryptococcosis in patients with malignant disease of reticuloendothelial system. Am J Clin Pathol 1954; 24: 1050-1072.
3. Kaplan MH, Rosen PP, Armstrong D. Cryptococcosis in a cancer hospital. Clinical and pathologic correlates in 46 patients. Cancer 1977; 39: 2265-2274.
4. Diamond RD. Cryptococcus neoformans. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th ed. New York: Churchill Livingstone, 2331-2340.
5. Hadley S, Karchmer AW. Fungal infections in solid organ transplant recipients. Infect Dis Clin North Am 1995; 9: 1045-1075.
6. Jabbour N, Reyes J, Kusne S, Martin M, Fung J. Cryptococcal meningitis after liver transplantation. Transplant 1996; 61: 146-167.
7. Rubin RH, Hooper DC. Central nervous system infection in the compromised host. Med Clin North Am 1985; 69: 281-297.
8. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS: 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-548.
9. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hather R, Dismukes WE, and the NIAID Mycoses Study Group and the AIDS Clinical Trials Group. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326: 83-89.
10. Stevens DA Itraconazole in cyclodextrin solution. Pharmacother 1999; 19: 603-611.
11. Van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE, and the NI-AID Mycoses Study Group and AIDS Clinical Trials Group. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997; 337: 15-21.
12. Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fan-Havard P, Eng RHK, Patterson TF, Pottage JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Gordon DS. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1996; 22: 315-321.
13. Clemons KV, Stevens DA. Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis. Antimicrob Agents Chemother 1998; 42: 899-902.
14. Graybill JR, Sobel J, Saag M, van der Horst C, Powderly W, Cloud G and the NIAID Mycoses Study Group and the AIDS Clinical Trials Group. Cerebrospinal fluid (CSF) hypertension in patients with AIDS and cryptococcal meningitis (CM) (abstract). Interscience Conference on Antimicrobial Agents and Chemotherapy 1997: 271.
15. Malessa R, Krams M, Hengge U, Weiller C, Reinhardt V, Volbracht L, Rauhut F, Brockmeyer NH. Elevation of intracranial pressure in acute AIDS-related cryptococcal meningitis. Clin Invest 1994; 72: 1020-1026.
16. Tang L-M. Ventriculoperitoneal shunt in cryptococcal meningitis with hydrocephalus. Surg Neurol 1990; 33: 314-319.
17. Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J. Med 1991; 91: 267-272.
18. Rex JH, Larsen RA, Dismukes WE, Cloud GA, Bennett JE. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine 1993; 72: 207-224.
19. Okun E, Butler WT. Ophthalmologic complications of cryptococcal meningitis. Arch Ophthalmol 1964; 71: 52-57.
20. Seaton RA, Verma N, Naraqi S, Wembri JP, Warrell D. Visual loss in immunocompetent patients with Cryptococcus neoformans var. gatti meninitis. Trans Royal Soc Trop Med 1997; 91: 44-49.
21. Seaton RA, Verma N, Naraqi S, Wembri JP, Warrell D. The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gatti meningitis. Trans Royal Soc Trop Med Hyg 1997; 91: 50-52.
22. Bingaman WE, Frank JI Malignant cerebral edema and intracranial hypertension. Neurol Clinics 1995;13:479-509.
23. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE. Risk of infection after cerebrospinal fluid shunt: An analysis of 884 first-time shunts. Acta Neurochir 1995; 136: 1-7.
24. Borgbjerg BM, Gjerris F, Albeck MJ, Hauerberg J, Borgesen SE. Frequency and causes of shunt revisions in different cerebrospinal fluid shunt types. Acta Neurochir 1995; 136: 189-194.
25. Park MK, Hospenthal DR, Bennett JE. Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. Clin Infect Dis 1999; 8: 629-633.
26. Imberti R, Bellinzona G, Ilardi M, Bruzzone P, Pricca P. The use of indomethacin to treat acute rises of intracranial pressure and improve global cerebral perfusion in a child with head trauma. Acta Anaesthesiol Scand 1997; 41: 536-540.
27. Fessler RD Sobel J, Guyot, L, Crane L, Vazquez J, Szuba MJ, Diaz FG. Management of elevated intracranial pressure in patients with cryptococcal meningitis. J Acquired Immunodeficiency Syndromes Human Retrovirol. 1998; 17: 137-142.
28. Bach MC, Tally PW, Godofsky EW. Use of cerebrospinal fluid shunts in patients having acquired immunodeficiency syndrome with cryptococcal meningitis and uncontrollable intracranial hypertension. Neurosurg 1997; 41: 1280-1283.
29. Mylonakis E, Merriman NA, Rich JD, Flanigan TP, Walters BC, Tashima KT, Mileno MD, Van der Horst CM. Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in patient with active AIDS-related cryptococcal meningitis. Diag Microbiol Infect Dis 1999; 34: 111-114.
30. Pickard JD, Czosnyka M. Management of raised intracranial pressure. J Neurol. Neurosurg Pschiatr 1993; 56: 845-858.